Stay updated on Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial
Sign up to get notified when there's something new on the Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial page.

Latest updates to the Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe clinical trial record for the Phase 3 Pexa-Vec and sorafenib study is available again, with its study details, participant criteria, treatment arms, outcome measures, and supporting documents.SummaryDifference100%

- Check16 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0; the study record page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA sitewide NIH banner announces transition updates and a change in terminology from “Artificial Intelligence” to “Super Intelligence.” The study page continues to display a 403 error.SummaryDifference1%

- Check30 days agoChange DetectedThe ClinicalTrials.gov 403 Forbidden page remains displayed, while the footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 error.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now shows a 403 Forbidden message instead of the study content, replacing the main content with an access-denied page while keeping site chrome visible.SummaryDifference0.5%

Stay in the know with updates to Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vaccinia Combo vs Sorafenib Alone in HCC Clinical Trial page.